Table 2

3-/4-MeSO2 substitution ratios and tissue/blood concentration ratios

RatioTriCBTetraCBPentaCBHexaCB
3-/4-MeS-CB ratio in feces1.2  ± 0.30.76  ± 0.210.18  ± 0.040.14  ± 0.04
3-/4-MeSO2-CB ratio in tissues
 Adipose tissue1.4  ± 0.21.8  ± 0.310.43  ± 0.130.30  ± 0.06
 Kidney1.2  ± 0.21.4  ± 0.240.14  ± 0.050.10  ± 0.04
 Liver1.5  ± 0.31.3  ± 0.260.52  ± 0.120.23  ± 0.06
 Lung0.30  ± 0.10.16  ± 0.050.03  ± 0.020.01  ± 0.01
Liver/blood ratio
 3-MeSO2-CB11.8  ± 3.014.1  ± 2.55.9  ± 1.017.0  ± 4.5
 4-MeSO2-CB16.5  ± 5.414.6  ± 3.83.6  ± 1.18.8  ± 2.5
Lung/blood ratio
 3-MeSO2-CB4.5  ± 1.23.4  ± 0.81.3  ± 0.35.7  ± 1.9
 4-MeSO2-CB31.2  ± 5.525.2  ± 5.810.4  ± 3.251.2  ± 8.0

Rats were given TriCB, TetraCB, PentaCB, and HexaCB intraperitoneally (342 μmol/kg, each) and killed 96 hr after injection.

  • Values represent mean ± SD of 3–4 rats.